Lv3
360 积分 2023-09-18 加入
Mouse model of Graves’ orbitopathy induced by the immunization with TSHR A and IGF-1R α subunit gene
2天前
已完结
A Biologic With Otologic Consequences: Analysis of Hearing Loss and Teprotumumab Using the FDA Adverse Event Reporting System
4天前
已完结
Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
18天前
已完结
evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease
1个月前
已完结
Trial of Lixisenatide in Early Parkinson’s Disease
1个月前
已完结
GLP-1, Parkinson’s Disease, and Neuroprotection
1个月前
已完结
GLP-1 programs the neurovascular landscape
1个月前
已完结
Efficacy, Safety, and Recurrence in Older Thyroid Eye Disease Patients Undergoing Teprotumumab Treatment
1个月前
已关闭
Pediatric Thyroid Eye Disease: Clinical Characteristics and Orbital Decompression Outcomes
1个月前
已完结
Pediatric hyperthyroidism and thyroid eye disease management
1个月前
已完结
皖公网安备34019202002308
